C29H35N5O5
Neat
533.63
-20°C
Room Temperature
Ergovaline; 2873-38-3; 059E2O9IV4; DTXSID10893243; 12'-Hydroxy-2'-methyl-5'alpha-(1-methylethyl)-ergotaman-3', 6', 18-trione; (6aR, 9R)-N-[(1S, 2S, 4R, 7S)-2-hydroxy-4-methyl-5, 8-dioxo-7-propan-2-yl-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9-tetrahydro-4H-indolo[4, 3-fg]quinoline-9-carboxamide; 12'-hydroxy-2'-methyl-5' alpha-(1-methylethyl)-ergotaman-3', 6', 18-trione; (6aR, 9R)-N-((1S, 2S, 4R, 7S)-2-hydroxy-4-methyl-5, 8-dioxo-7-propan-2-yl-3-oxa-6, 9-diazatricyclo(7.3.0.02, 6)dodecan-4-yl)-7-methyl-6, 6a, 8, 9-tetrahydro-4H-indolo(4, 3-fg)quinoline-9-carboxamide; RefChem:137563; DTXCID401323176; ERGOTAMAN-3', 6', 18-TRIONE, 12'-HYDROXY-2'-METHYL-5'-(1-METHYLETHYL)-, (5'ALPHA)-R; N-(2-hydroxy-4-methyl-5, 8-dioxo-7-(propan-2-yl)-3-oxa-6, 9-diazatricyclo(7.3.0.02, 6)dodecan-4-yl)-6-methyl-6, 11-diazatetracyclo(7.6.1.02, 7.012, 16)hexadeca-1(16), 2, 9, 12, 14-pentaene-4-carboxamide; UNII-059E2O9IV4; SCHEMBL14887086; CHEBI:184047; FE31073; Ergotaman-3', 6', 18-trione, 12'-hydroxy-2'-methyl-5'-(1-methylethyl)-, (5'alpha)-; NS00094895; Q5385834; (6aR, 9R)-N-[(1S, 2S, 4R, 7S)-2-hydroxy-4-methyl-5, 8-dioxo-7-propan-2-yl-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9-tetrahydro-4H-indolo[4 and 3-g]quinoline-9-carboxamide
(6aR, 9R)-N-[(1S, 2S, 4R, 7S)-2-hydroxy-4-methyl-5, 8-dioxo-7-propan-2-yl-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9-tetrahydro-4H-indolo[4 and 3-fg]quinoline-9-carboxamide
InChI=1S/C29H35N5O5/c1-15(2)24-26(36)33-10-6-9-22(33)29(38)34(24)27(37)28(3,39-29)31-25(35)17-11-19-18-7-5-8-20-23(18)16(13-30-20)12-21(19)32(4)14-17/h5,7-8,11,13,15,17,21-22,24,30,38H,6,9-10,12,14H2,1-4H3,(H,31,35)/t17-,21-,22+,24+,28-,29+/m1/s1